By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    AI-guided technique maps tumor blood supply for precise brain cancer therapy
    By
    msadmin
    July 21, 2026
    Belgian techbio startup Sightera raises $3.2M for AI-designed molecular glues
    By
    msadmin
    July 21, 2026
    FPT launches MediSight AI framework for healthcare and life sciences
    By
    msadmin
    July 21, 2026
    Boehringer Ingelheim taps Immunai AI platform in $15 million deal
    By
    msadmin
    July 20, 2026
    New Zealand health system partners with NHS for AI scribe rollout
    By
    msadmin
    July 20, 2026
  • Spotlight
    SpotlightShow More
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
    ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases
    By
    msadmin
    July 12, 2026
    Strategic healthcare AI governance framework abstract illustration
    Building a Resilient Healthcare AI Strategy: Insights from Industry Leaders
    By
    msadmin
    May 15, 2026
    Pharma AI Alliance Expands: Owkin and AstraZeneca Deploy New Drug Discovery Models
    By
    msadmin
    May 14, 2026
    7 Must-Attend MedTech Events in South Africa for 2025
    By
    Jostel Owusu
    August 9, 2025
  • Articles
    ArticlesShow More
    Hemispheric raises $52M for AI brain foundation model
    By
    msadmin
    July 19, 2026
    OpenEvidence and Boston Children’s partner to study AI’s clinical impact
    By
    msadmin
    July 19, 2026
    Google SensorFM trains on one trillion minutes of wearable health data
    By
    msadmin
    July 19, 2026
    Doudna Lab uses AI to design novel gene-editing enzymes from scratch
    By
    msadmin
    July 18, 2026
    AI-powered biosimulation shakes up animal testing in drug development
    By
    msadmin
    July 18, 2026
  • Events
    EventsShow More
    Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
    By
    msadmin
    June 19, 2026
    HIMSS APAC 2026: Re-engineering APAC Health Systems in the AI Era
    By
    msadmin
    June 9, 2026
    AIMed 2026: Bridging the Gap Between AI Promise and Clinical Reality in Kraków
    By
    msadmin
    April 30, 2026
    7 Must-Attend MedTech Events in South Africa for 2025
    By
    Jostel Owusu
    August 9, 2025
    Cleveland Clinic’s First AI Summit Signals Bold Future for Healthcare
    By
    msadmin
    July 19, 2025
  • About
    • Mission
    • Services
    • Contact
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • Events
  • About
  • Quick Links
    • Home
    • News & Alerts
    • Spotlight
    • Articles
    • Events
  • About MedSpark
    • Our Purpose & Vision
    • Services
    • Contact
Follow US
News & Alerts

Mount Sinai AI model maps how genes function together in cells

Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts, revealing new insights into disease and drug targets.

MSAdmin
By
msadmin
MSAdmin
Bymsadmin
MedTech AI & Cybersecurity News
Follow:
Published: July 19, 2026
Share
1 Min Read
SHARE

Researchers at the Icahn School of Medicine at Mount Sinai have created a gene set foundation model (GSFM) that learns how genes work together inside human cells by analyzing patterns from millions of published gene sets.

The model draws inspiration from large language models like ChatGPT, learning the “meaning” of genes through their biological context rather than through raw expression data alone. A single gene can play different roles depending on cellular conditions, much like a word carries different meanings depending on the sentence it appears in.

GSFM was trained on gene sets from hundreds of thousands of independent studies and can identify the function of poorly understood genes, highlight genes involved in disease processes, and suggest potential new drug targets and biomarkers. The model demonstrated strong performance in predicting gene-gene and gene-function relationships that were later confirmed experimentally.

The research, published in Patterns, is openly accessible at gsfm.maayanlab.cloud. Future plans include combining GSFM with language models to generate natural-language explanations of gene functions and integrating it with drug-focused AI models to predict drug-cell interactions.

TAGGED:AIAI Drug Discoverybiomarker discoverygene set foundation modelGenomicsIcahn School of MedicineMount Sinai
SOURCES:Mount Sinai
Share This Article
Facebook Copy Link Print
MSAdmin
Bymsadmin
Follow:
MedTech AI & Cybersecurity News
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

banner-medspark-horiz

You Might Also Like

ArticlesNews & Alerts

Google’s TabFM Makes Accurate Predictions Without Fine-Tuning Per Dataset

By
msadmin
July 12, 2026
News & Alerts

DeepMind unveils AI co-clinician research for triadic care model

By
msadmin
July 19, 2026
AI-powered drug discovery concept showing a holographic molecular structure analyzed by neural networks in a sleek pharmaceutical laboratory with teal and gold lighting
Articles

How Machine Learning Is Reshaping Pharmaceutical R&D

By
msadmin
July 12, 2026
News & Alerts

Boehringer Ingelheim taps Immunai AI platform in $15 million deal

By
msadmin
July 20, 2026
Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal